7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Lexicon Pharmaceuticals, Inc
(NASDAQ:LXRX) 

LXRX stock logo

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the t...

Founded: 1995
Full Time Employees: 184
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Lexicon Pharmaceuticals Days Payable Outstanding ttm (DPO)
202110 202111 202112 202201 202202 202203 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.230.450.680.91.131.351.58Billion
Lexicon Pharmaceuticals Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0108.01216.02324.03432.04540.05648.06756.07
Lexicon Pharmaceuticals Days Inventory Outstanding ttm (DIO)
202110 202111 202112 202201 202202 202203 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01,1682,3363,5044,6725,8407,0088,176
Lexicon Pharmaceuticals Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.66-0.57-0.47-0.38-0.28-0.19-0.090
Lexicon Pharmaceuticals Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.66-0.57-0.47-0.38-0.28-0.19-0.090
Lexicon Pharmaceuticals Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.180.360.540.720.91.071.25
Lexicon Pharmaceuticals P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0778.641,557.282,335.933,114.573,893.214,671.855,450.5
Lexicon Pharmaceuticals (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -6.39-5.47-4.56-3.65-2.74-1.82-0.910
Lexicon Pharmaceuticals P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.410.471.352.233.113.994.875.75
No extra charts and metrics for this ticker.